Real life efficacy, renal and lipid profile data of tenofovir alafenamide in switched chronic hepatitis B patients
dc.authorid | Yıldız, İlknur Esen/0000-0003-2987-0483 | |
dc.authorid | Karabay, Oğuz Oguz/0000-0003-1514-1685 | |
dc.authorwosid | Yıldız, İlknur Esen/AAR-3407-2021 | |
dc.authorwosid | Karabay, Oğuz Oguz/HHN-5893-2022 | |
dc.contributor.author | Güner, Rahmet | |
dc.contributor.author | Yörük, Gülşen | |
dc.contributor.author | Karabay, Oğuz | |
dc.contributor.author | Yamazhan, Tansu | |
dc.contributor.author | Baykam, Nurcan | |
dc.contributor.author | Yıldırım, Mustafa | |
dc.contributor.author | İnce, Nevin | |
dc.date.accessioned | 2023-07-26T11:50:44Z | |
dc.date.available | 2023-07-26T11:50:44Z | |
dc.date.issued | 2022 | |
dc.department | DÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları Ana Bilim Dalı | en_US |
dc.description.abstract | [Bastract Not Available] | en_US |
dc.identifier.endpage | S859 | en_US |
dc.identifier.issn | 0168-8278 | |
dc.identifier.issn | 1600-0641 | |
dc.identifier.startpage | S858 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/12417 | |
dc.identifier.volume | 77 | en_US |
dc.identifier.wos | WOS:000826275104255 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.institutionauthor | İnce, Nevin | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Journal of Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | $2023V1Guncelleme$ | en_US |
dc.title | Real life efficacy, renal and lipid profile data of tenofovir alafenamide in switched chronic hepatitis B patients | en_US |
dc.type | Conference Object | en_US |